Monocle Acquisition Corporation Files for a $150M SPAC
by Kristi Marvin on 2018-11-20 at 9:27am

Monday evening, Monocle Acquisition Corporation (MNCL), filed for $150 million SPAC IPO.  Monocle is being led by Eric Zahler, as President, CEO and Director, and is a co-founder and Managing Director of Sagamore Capital, a private equity firm pursuing investments in the aerospace and defense, industrial electronics and selected business service markets.  Sai S. Devabhaktuni, formerly the Executive Vice President and Head of Corporate Distressed Portfolio Management at PIMCO, will be Chairman of the Board of Directors.

As for the name “Monocle”, The Monocle Group LLC is an investment firm founded by Mr. Devabhaktuni that invests in inefficient markets with an emphasis on debt, equity and other obligations of financially stressed businesses. Although, it does conjure up images of Mr. Peanut.

Looking at this SPAC’s structure, we see a 100% in trust, one share + one warrant deal, with 21 months to find an acquisition. However, if Monocle needs a three month extension for a full 24 months, they must deposit into the trust account $1,500,000, or $0.10 per share.

Monocle table

Furthermore, Cowen is participating in the at-risk capital of $5 million, by purchasing 83,333 units of the total 500,000 units at $10.00. $833,330 is a size-able purchase by an underwriter, so Cowen has a considerable amount at risk too.

This is a fairly middle of the road SPAC – mid size, mid-terms, mid-team.  As for the terms, given the current SPAC climate, it will be interesting to see if they need to amend by over-funding the trust to 101% or coming down to 18 months once it gets closer to pricing.

However, this does make SPAC #45 if it prices in 2018.  There should be one or two more that file this year, but it remains to be seen if those price in December or January. Stay tuned.

Cowen and Chardan are joint book-running managers.
Greenberg Traurig, LLP and Ellenoff Grossman & Schole LLP are issuer’s counsel and underwriter’s counsel, respectively.

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved